Skip to content

Survey study, 1989

Are there neurochemical differences in the premenstrual phase for women with menstrual migraines?

Women with menstrual migraines show reduced brain hormone responses to a nerve-stimulating drug during the premenstrual phase, but not other times. This suggests a specific nerve system weakness that may explain premenstrual migraines.

Early or limited evidence 9 women with menstrual migraines and 6 healthy control women

What they did

Cross-sectional lab study of 9 women with menstrual migraines and 6 healthy control women. Researchers gave clonidine (0.075 mg intravenously) in two menstrual cycle phases: early luteal and late luteal (premenstrual). They measured stress hormones and brain chemicals in response to the drug.

What they found

In both cycle phases, clonidine similarly reduced norepinephrine and a related chemical in migraine patients and controls. However, in migraine patients, clonidine stimulated beta-endorphin and growth hormone only in the early luteal phase, not during the premenstrual phase. In healthy controls, cycle phase did not affect hormone responses. This suggests reduced sensitivity of a particular nerve receptor during the premenstrual period in migraine patients.

What it means for you

Women with menstrual migraines may have a specific biological vulnerability in their nerve systems during the premenstrual phase. This could explain why migraines worsen at this time. The study is very small and laboratory-based, so findings need replication in larger studies.

9

Women with menstrual migraines

6

Healthy control women

0.075 mg

Clonidine dose (intravenous)

About the study

Original title
Premenstrual failure of alpha-adrenergic stimulation on hypothalamus-pituitary responses in menstrual migraine
Authors
Facchinetti F, Martignoni E, Nappi G et al.
Journal
Psychosomatic medicine
Year
1989
Study design
Survey study
What was tested
Clonidine (0.075 mg intravenous) challenge test

Topics